Loading...
XNAS
UPC
Market cap2mUSD
Dec 04, Last price  
4.12USD
1D
16.71%
1Q
16.06%
IPO
-1.20%
Name

Universe Pharmaceuticals Inc

Chart & Performance

D1W1MN
XNAS:UPC chart
P/E
P/S
0.10
EPS
Div Yield, %
Shrs. gr., 5y
-72.22%
Rev. gr., 5y
-7.07%
Revenues
23m
-28.74%
28,514,18033,229,31630,703,96047,982,03140,143,15132,308,73523,024,458
Net income
-9m
L+41.61%
7,602,9337,551,4657,558,22211,319,952-8,736,566-6,163,061-8,727,298
CFO
-10m
L
4,455,59913,203,7556,115,157-2,055,847-1,312,3461,120,082-9,506,683

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
IPO date
Mar 23, 2021
Employees
224
Domiciled in
CN
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT